FDA Probe of Diabetes Drugs Hurts Makers’ Stock – CNBC.com

FDA Probe of Diabetes Drugs Hurts Makers' Stock
CNBC.com
Novo makes the once-a-day injection Victoza, which brought in about $1.7 billion last year. That's far less than the Merck drugs, but Novo Nordisk is known as the world's biggest seller of insulin and about 80 percent of its total revenue comes from

and more »

View full post on world asthma day – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *